Axsome Therapeutics' experimental drug to treat attention deficit hyperactivity disorder (ADHD) helped improve symptoms of the developmental disorder in adults, it said on Tuesday, meeting the main ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent ...

Ingredion is set to construct a new 9,000-square-foot facility in Cedar Rapids, with assistance from the Iowa Economic ...

At the current market price of Tk218.90 per share, the transaction is estimated to be worth approximately Tk33 crore ...

Senores Pharmaceuticals Ltd, a pharmaceutical formulations manufacturer that made its stock market debut in December last year, plans to focus on product acquisitions to expand its pipeline, a top ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Indian Pharmaceuticals Market has delivered marginally lower revenue at 7.5% year on year in February 2025, compared to 8.7% year on year in January 2025. Overall, growth in February was driven by ...

Bangladesh's pharmaceutical exports posted steady growth in the first eight months of the current fiscal year, buoyed by rising demand from developed markets, though a sharp decline in February ...

“We are essentially just going in the direction that has been so successful for the pharmaceutical industry,” AgPlenus CEO Dan Gelvan says of his company’s approach to develop crop protection products ...

We are playing a positive role, and we are expecting that Indian pharma products would not get the same tariff treatment as being meted out to steel and auto components,” said Shah. On its part ...